- $78 BnWorld market, 2023
- $154.9 BnProjected, 2033
- 7.1%Growth a year (CAGR)
- –Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$32.8 Bn
5.1% a year · 42% of the world -
2
China
$6.3 Bn
8.6% a year · 8% of the world -
3
Canada
$6.2 Bn
7.1% a year · 8% of the world -
4
Japan
$4.8 Bn
7.6% a year · 6.2% of the world -
5
Germany
$2.9 Bn
5.3% a year · 3.7% of the world -
6
France
$2.1 Bn
6.1% a year · 2.8% of the world -
7
UK
$2 Bn
5.1% a year · 2.6% of the world -
8
Brazil
$2 Bn
8.1% a year · 2.5% of the world -
9
Italy
$1.9 Bn
6.6% a year · 2.4% of the world -
10
Ecuador
$1.6 Bn
7.7% a year · 2% of the world
Diabetes Management by country and region
Spain
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 110,629 papers since 2021
- Corrigendum to "Fingernail analysis in diagnosis and management of diabetes mellitus" [Clin. Chim. Acta 578 (2026) 120490]. Clinica chimica acta; international journal of clinical chemistry, 2026
- Knowledge, Perspectives, and Experiences of Women in Kuwait Regarding GLP-1/GIP-Based Medications for Weight Management: A Cross-Sectional Study. Clinical therapeutics, 2026
- Risk-stratified treatment of type 1 autoimmune pancreatitis: A narrative review positioning rituximab and inebilizumab. European journal of internal medicine, 2026
- Coronary Microvascular Dysfunction: Identification, Special Populations, and Management Strategies. Interventional cardiology clinics, 2026
- The 2026 state of inpatient diabetes management: a rich history, an exciting future. BMJ open diabetes research & care, 2026
Patients: Diabetes (adults)
| Place | Value | Year |
|---|---|---|
| World | 14.1 | 2022 |
| Australia | 8.1 | 2022 |
| Brazil | 12.9 | 2022 |
| Canada | 6.8 | 2022 |
| China | 11.2 | 2022 |
| Ecuador | 12.7 | 2022 |
| Egypt | 27.8 | 2022 |
| France | 2.7 | 2022 |
| Germany | 6.6 | 2022 |
| India | 22.6 | 2022 |
| Italy | 7.2 | 2022 |
| Japan | 6.4 | 2022 |
| Kenya | 5.6 | 2022 |
| Malaysia | 26.7 | 2022 |
| Mexico | 14.3 | 2022 |
| New Zealand | 9.0 | 2022 |
| Philippines | 13.2 | 2022 |
| Russia | 8.1 | 2022 |
| Saudi Arabia | 20.8 | 2022 |
| Singapore | 13.1 | 2022 |
| South Africa | 13.9 | 2022 |
| Spain | 3.6 | 2022 |
| Thailand | 12.3 | 2022 |
| UAE | 26.1 | 2022 |
| UK | 8.8 | 2022 |
| US | 12.5 | 2022 |
Compare Diabetes Management side by side
Key companies in Diabetes Management
Medtronic
Dexcom
Roche
Quick answers
How big is the Diabetes Management market?
The world Diabetes Management market was worth about $78 Bn in 2023 and is projected to reach $154.9 Bn by 2033, growing 7.1% a year (CAGR).
Which country has the largest Diabetes Management market?
The US is the largest of the 24 countries we cover, at $32.8 Bn in 2023. India grows fastest, at 10.1% a year.
How much research is published on Diabetes Management?
PubMed lists about 110,629 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.